Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Welch

Showing results (481-490 of 704) with videos related to

Pageof 71
Sort By:
Infection and Immunity|March 28, 2018
Role of Sca2 and RickA in the Dissemination of Rickettsia parkeri in Amblyomma maculatumEmma K Harris, Krit Jirakanwisal, Victoria I Verhoeve, et al.
Nature Communications|June 27, 2022
A patatin-like phospholipase mediates Rickettsia parkeri escape from host membranesGina M Borgo, Thomas P Burke, Cuong J Tran, et al.
The American Journal of Emergency Medicine|December 1, 2014
Access to care issues and the role of EDs in the wake of the Affordable Care ActAlexander T Janke, Aaron M Brody, Daniel L Overbeek, et al.
Research Communications in Chemical Pathology and Pharmacology|June 1, 1978
The identification and measurement of two new metabolites of naltrexone in human urineE J Cone, C W Gorodetzky, W D Darwin, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophagesMaria C Virgilio, Barkha Ramnani, Thomas Chen, et al.
Nature Communications|July 1, 2024
HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophagesMaria C Virgilio, Barkha Ramnani, Thomas Chen, et al.
The New England Journal of Medicine|June 25, 1998
An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residentsJ P Nuorti, J C Butler, J M Crutcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase Ib trial of bryostatin 1 in patients with refractory malignanciesS Grant, J Roberts, E Poplin, et al.
Dalton Transactions (Cambridge, England : 2003)|April 7, 2018
Reversible modulation of the redox characteristics of acid-sensitive molybdenum and tungsten scorpionate complexesAlexander J Heyer, Philip J Shivokevich, Shelby L Hooe, et al.
Molecular Metabolism|April 2, 2015
The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitisKristine Griffett, Ryan D Welch, Colin A Flaveny, et al.
Pageof 71

Showing results (481-490 of 704) with videos related to

Sort By:
Pageof 71
Infection and Immunity|March 28, 2018
Role of Sca2 and RickA in the Dissemination of Rickettsia parkeri in Amblyomma maculatumEmma K Harris, Krit Jirakanwisal, Victoria I Verhoeve, et al.
Nature Communications|June 27, 2022
A patatin-like phospholipase mediates Rickettsia parkeri escape from host membranesGina M Borgo, Thomas P Burke, Cuong J Tran, et al.
The American Journal of Emergency Medicine|December 1, 2014
Access to care issues and the role of EDs in the wake of the Affordable Care ActAlexander T Janke, Aaron M Brody, Daniel L Overbeek, et al.
Research Communications in Chemical Pathology and Pharmacology|June 1, 1978
The identification and measurement of two new metabolites of naltrexone in human urineE J Cone, C W Gorodetzky, W D Darwin, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophagesMaria C Virgilio, Barkha Ramnani, Thomas Chen, et al.
Nature Communications|July 1, 2024
HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophagesMaria C Virgilio, Barkha Ramnani, Thomas Chen, et al.
The New England Journal of Medicine|June 25, 1998
An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residentsJ P Nuorti, J C Butler, J M Crutcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase Ib trial of bryostatin 1 in patients with refractory malignanciesS Grant, J Roberts, E Poplin, et al.
Dalton Transactions (Cambridge, England : 2003)|April 7, 2018
Reversible modulation of the redox characteristics of acid-sensitive molybdenum and tungsten scorpionate complexesAlexander J Heyer, Philip J Shivokevich, Shelby L Hooe, et al.
Molecular Metabolism|April 2, 2015
The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitisKristine Griffett, Ryan D Welch, Colin A Flaveny, et al.
Pageof 71